Avalo Therapeutics, Inc.
AVTXNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for AVTX. That does not mean none is planned.
Get an email about AVTX's next catalysts
Track Avalo Therapeutics (AVTX) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 2 past
No catalysts found.
Market Overview
Stock performance and key metrics
FP01
Chronic Refractory Cough
AVTX-002
Non-Eosinophilic Asthma
CERC-301
Major Depressive Disorder
AVTX-009 Regimen 1
Hidradenitis Suppurativa
AVTX-009 Regimen 2
Hidradenitis Suppurativa
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
FP01 | Phase 2 | Chronic Refractory Cough | - | - |
AVTX-002 | Phase 2 | Non-Eosinophilic Asthma | - | - |
CERC-301 | Phase 2 | Major Depressive Disorder | - | - |
AVTX-009 Regimen 1 | Phase 2 | Hidradenitis Suppurativa | - | - |
AVTX-009 Regimen 2 | Phase 2 | Hidradenitis Suppurativa | - | - |
Frequently asked questions
What is in Avalo Therapeutics, Inc.'s drug pipeline?β
CatalystAlert tracks 5 drug candidates in Avalo Therapeutics, Inc.'s (AVTX) pipeline across Phase 2. Its lead program is AVTX-002 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Avalo Therapeutics, Inc.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for Avalo Therapeutics, Inc. (AVTX) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track AVTX biotech catalysts?β
Add AVTX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Avalo Therapeutics, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
